Drug Database · Clinicians

Nystatin

Brands (29) Adnyst, Afunginal, Bionyst…Show all

Polyene Antifungal US FDA class
Antifungal PH FDA category

Rx · Prescription drug29 PH productsPNF-listed
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID 88a0a22e-8d6b-42aa-b225-2d57fb5b3a97, version date November 12, 2025 (Nystatin · Chartwell Governmental & Specialty RX, LLC). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • INDICATIONS AND USAGE Nystatin oral suspension is indicated for the treatment of infections of the oral cavity caused by Candida albicans .
US FDA label
Full indications and usage US FDA label

INDICATIONS AND USAGE Nystatin oral suspension is indicated for the treatment of infections of the oral cavity caused by Candida albicans.

Contraindications

CONTRAINDICATIONS Nystatin is contraindicated in patients with a history of hypersensitivity to nystatin or any of the suspension components.

US FDA label

Dosing: Adult

Dosage and administration (US label) US FDA label

DOSAGE AND ADMINISTRATION Infants: 2 mL (200,000 units) four times daily (1 mL in each side of mouth). Pediatric patients and adults: 4 to 6 mL (400,000 to 600,000 units) four times daily (one-half of dose in each side of mouth). NOTE: Limited clinical studies in neonates, including premature and low-birth weight neonates, indicate that 1 mL (100,000 units) four times daily is effective.

Local treatment should be continued at least 48 hours after perioral symptoms have disappeared and/or cultures returned to normal. It is recommended that the drug be retained in the mouth as long as possible before swallowing.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Oral suspension: 100,000 IU/mL, 100,000 units/mL
  • Suspension for oral drops: 100,000 units/mL
  • Ointment ointment: 100,000 units
  • Suspension: 100,000 units/mL

Registered products in the Philippines

29 products registered with the Food and Drug Administration (FDA) Philippines list Nystatin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products29
Philippine FDA-registered products for Nystatin
Package insert
AdnystNystatin
100,000 units/mL Oral SuspensionAmber Glass Bottle x 12 mL
Rx
Somatec Pharmaceuticals Ltd.Bangladesh
Advance Pharma Distribution Corp.Importer: Bridgemark Marketing
DRP-3559-05
Nov 23, 2027
AfunginalNystatin
100,000 I.U./mL Oral SuspensionAmber Glass Bottle x 12 mL and 30 mL w/ Calibrated Dropper (Box of 1's)
Rx
The ACME Laboratories LimitedBangladesh
Remed Pharmaceuticals, Inc.Importer: Euro Generics International Phils., Inc.
DRP-587
Aug 29, 2028
BionystNystatin
100,000 units/mL Oral SuspensionAmber Glass Bottle x 12 mL
Rx
Somatec Pharmaceuticals Ltd.Bangladesh
All-Bio Pharma, Inc.Importer: Bridgemark Marketing
DRP-3559-01
Nov 23, 2027
EmnystatNystatin
100,000 IU/mL Oral Suspension (Drops)12 mL Net Content in 15 mL Capacity Amber Glass Bottle with Plastic Dropper (Box of 1's)
Rx
Norris Medicines LimitedIndia
Emhealthcare Pharma Traders Inc.Importer: Medethix, Inc.Trader: Aumgen Pharma LLP.
DRP-5479-01
Aug 26, 2029
FungystNystatin
100,000 IU/mL Oral SuspensionAmber glass boston brown bottle x 30 mL (Box of 1's); Amber glass boston brown bottle x 12 mL in 15 mL capacity bottle (Box of 1's)
Rx
Drugmaker's Laboratories, Inc.Philippines
—
DRP-13438
Nov 16, 2028
GozenystNystatin
100,000 IU/mL Oral SuspensionAmber Glass Bottle Sealed with ROPP Cap x 30 mL with Plastic Dropper (Box of 1's)
Rx
S Kant Healthcare Ltd.India
Applied Pharmaceutical Distribution IncImporter: Medinova Pharmaceutical Inc.
DRP-15585-01
Aug 6, 2029
HiztatinNystatin
100,000 Units/mL Oral Suspension30 mL Amber glass bottle with aluminum PP cap and plastic dropper (Box of 1's)
Rx
Kwality Pharmaceuticals Ltd.India
Pharmacia HizkiahImporter: Pharma-Surrey International, Inc.
DRP-7142-02
Apr 3, 2027
MedinystNystatin
100,000 IU/mL Oral SuspensionAmber Glass Bottle Sealed with ROPP Cap x 30 mL with Plastic Dropper (Box of 1's)
Rx
S Kant Healthcare Ltd.India
GA2 Pharmaceutical IncImporter: Medinova Pharmaceutical Inc.
DRP-15585-03
Aug 6, 2029
MyconilNystatin
100,000 IU / mL Oral Suspension (Oral Drops)Boston Round Amber Bottle with pilfer proof aluminum cap (printed Amson logo) and medicine plastic dropper x 30 mL (Box of 1's)
Rx
Amson Vaccines & Pharma (Pvt.) Ltd.Pakistan
SAHAR INTERNSahar International Trading, Inc.ATIONAL TRADING, INC.Importer: Sahar International Trading, Inc.
DRP-7275
Dec 11, 2029
MystinNystatin
100,000 Units/mL Oral SuspensionAmber Bottle x 12 mL in 15 mL and 30 mL with medicine dropper (Box of 1's)
Rx
Scheele Laboratories Phils., Inc.Philippines
—
DRP-4894
Nov 6, 2028
NovastatinNystatin
100,000 IU/mL Oral SuspensionAmber Glass Bottle Sealed with ROPP Cap x 30 mL with Plastic Dropper (Box of 1's)
Rx
S Kant Healthcare Ltd.India
Medinova Pharmaceutical Inc..
DRP-15585
Aug 6, 2029
NysaphNystatin
Suspension for Oral Drops 100,000 units/mL12 mL Amber Bottle with White Screw Pilfer Proof Cap; 15 mL Amber Bottle with White Screw Pilfer Proof Cap; 30 mL Amber Bottle with White Screw Pilfer Proof Cap
Rx
Sapphire Lifesciences Pvt. LtdIndia
Nelpa Lifesciences, Inc.
DRP-5138
Feb 13, 2029
NystNystatin
100,000 units/mL Oral SuspensionAmber Glass Bottle x 12mL
Rx
Somatec Pharmaceuticals Ltd.Bangladesh
Bridgemark Marketing
DRP-3559
Nov 23, 2027
NystajingNystatin
100,000 Units / mL Oral SuspensionAmber Bottle x 30 mL with medicine dropper (Box of 1's)
Rx
Scheele Laboratories Phils., Inc.Philippines
TGIF Pharmaceutical Trading Inc.
DRP-4894-01
Nov 6, 2028
NystarexNystatin
100,000 units/mL Oral SuspensionPET Amber Bottle x 30 mL with pilfer proof cap (Box of 1's)
Rx
Opal Laboratories (Pvt.) LimitedPakistan
Rexmed Pharmaceutical SalesImporter: Accesspoint International Trading Inc.
DRP-6556-02
Mar 7, 2031
NystcareNystatin
100,000 Units/mL Oral SuspensionPET Amber Bottle x 30 mL with pilfer proof cap (Box of 1's)
Rx
Opal Laboratories (Pvt.) LimitedPakistan
Medcare PharmaceuticalsImporter: Accesspoint International Trading Inc.
DRP-6556-05
Mar 7, 2031
NystorNystatin
100,000 units/Ointment OintmentAluminum collapsible tube with white HPDE cap x 15 g and 30 g (Box of 1's)
Rx
TORRENT PHARMACEUTICALS LTD.India
Torrent Pharma Philippines, Inc.
DR-XY48888
Oct 2, 2028
NystrinNystatin
100,000 units/mL Suspension (Oral Drops)Amber Bottle x 30 mL with Golden Yellow Aluminum Screw Cap with Dropper (Box of 1's)
Rx
Harmann Pharmaceutical Labs. (Pvt.) Ltd.Pakistan
Raquel-Abbas Pharmaceuticals & General Merchandise.
DRP-5556
Sep 30, 2029
NyszacNystatin
100,000 IU/mL Oral Suspension (Drops)12 mL Net Content in 15 mL Capacity Amber Glass Bottle with Plastic Dropper (Box of 1's)
Rx
Norris Medicines LimitedIndia
Medethix, Inc.Trader: Alvita Pharma Pvt. Ltd.
DRP-5479
Aug 26, 2029
NytasethNystatin
100,000 units/mL Oral SuspensionPET Amber Bottle x 30 mL with pilfer proof cap (Box of 1's)
Rx
Opal Laboratories (Pvt.) LimitedPakistan
Eliset Pharmaceutical, Inc.Importer: Accesspoint International Trading Inc.
DRP-6556-3
Mar 7, 2031
OraseaNystatin
100,000 Units/mL Oral Suspension30 mL Amber Glass Bottle with Aluminum PP Cap and Plastic Dropper (Box of 1's)
Rx
Kwality Pharmaceuticals Ltd.India
Seapharma International, Inc.Importer: Pharma-Surrey International, Inc.
DRP-7142-03
Apr 3, 2027
OrastatNystatin
100,000 Units/mL Oral Suspension30 mL Amber glass bottle with aluminum PP cap and plastic dropper (Box of 1's)
Rx
Kwality Pharmaceuticals Ltd.India
Pharma-Surrey International, Inc.
DRP-7142
Apr 3, 2027
OrastinNystatin
100,000 I.U./mL Oral SuspensionAmber Glass Bottle x 12 mL w/ Calibrated Dropper (Box of 1's)
Rx
The ACME Laboratories LimitedBangladesh
Euro Generics International Phils., Inc.
DRP-587-03
Aug 29, 2028
RetanystNystatin
100,000 IU/mL Oral SuspensionAmber Glass Bottle Sealed with ROPP Cap x 30 ml with Plastic Dropper (Box of 1's)
Rx
S Kant Healthcare Ltd.India
Reta DrugImporter: Medinova Pharmaceutical Inc.
DRP-15585-02
Aug 6, 2029
RextatinNystatin
100,000 Units/mL Oral Suspension30 mL Amber glass bottle with aluminum PP cap and plastic dropper (Box of 1's)
Rx
Kwality Pharmaceuticals LtdIndia
Rexmed Pharmaceutical SalesImporter: Pharma-Surrey International, Inc.
DRP-7142-04
Apr 3, 2027
RynystatinNystatin
100,000 units/mL Suspension for Oral Drops12 mL Amber Bottle with White Screw Pilfer Proof Cap (Box of 1’s); 15 mL Amber Bottle with White Screw Pilfer Proof Cap (Box of 1’s); 30 mL Amber Bottle with White Screw Pilfer Proof Cap (Box of 1’s)
Rx
Enicar Pharmaceuticals Pvt. Ltd.India
Rinon Care Pharma, Inc.Importer: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd.
DRP-5138-02
Feb 13, 2029
TeranystNystatin
100,000 IU/mL Oral SuspensionAmber glass boston brown bottle x 30 mL (Box of 1's); Amber glass boston brown bottle x 12 mL in 15 mL capacity (Box of 1's)
Rx
Drugmaker's Laboratories, Inc.Philippines
Terramedic, Inc.
DRP-13438-01
Nov 16, 2028
Z-NystNystatin
100,000 units/mL Oral SuspensionPET Amber Bottle x 30 mL with pilfer proof cap (Box of 1's)
Rx
Opal Laboratories (Pvt.) LimitedPakistan
Accesspoint International Trading Inc.
DRP-6556
Mar 7, 2031
ZystinNystatin
100,000 units/mL Oral SuspensionAmber Glass Bottle x 12 mL
Rx
Somatec Pharmaceuticals Ltd.Bangladesh
JZ PharmazoneImporter: Bridgemark Marketing
DRP-3559-03
Nov 23, 2027

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Warnings/Precautions

Warnings and precautions (US label) US FDA label

PRECAUTIONS General Discontinue treatment with nystatin if sensitization or irritation is reported during use. Nystatin is not effective in the treatment of systemic mycoses since it is not significantly absorbed from the gastrointestinal tract. Information for the Patient Patient should be advised to retain nystatin in the mouth as long as possible and to continue its use for at least 2 days after symptoms have subsided.

There should be no interruption or discontinuation of the medication until the prescribed course of treatment is completed, even though symptomatic relief may occur within a few days. If symptoms of local irritation develop, the physician should be notified immediately. Laboratory Tests If there is a lack of therapeutic response, appropriate microbiological studies (e.g., KOH smears and/or cultures) should be repeated to confirm the diagnosis of candidiasis and rule out other pathogens before instituting another course of therapy.

Carcinogenesis, Mutagenesis, Impairment of Fertility No long-term animal studies have been performed to evaluate the carcinogenic potential of nystatin. In mice exposed to nystatin 50 mg/kg by injection, an increased incidence of chromosomal aberrations, consisting primarily of chromatid breaks, was observed in bone marrow cells.

However, there have been no studies to determine the mutagenicity of orally-administered nystatin or its effects on fertility in males or females. Pregnancy Teratogenic effects Teratogenicity studies have not been conducted with nystatin. It is also not known whether nystatin can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.

Nystatin should be given to a pregnant woman only if clearly needed. Nonteratogenic effects In one rat reproductive study, nystatin was administered orally to pregnant rats in single doses of 100, 500, or 3000 mg/kg on the ninth day of gestation, or as multiple doses of 500 mg/kg/day on gestation days 1-20, 1-4, 7-10, 11-14, or 15-18.

It was found that nystatin had a slight abortive effect when used during the whole period of pregnancy. No abnormalities were seen in surviving fetuses. Although no adverse effects or complications have been attributed to the use of intra-vaginal nystatin in neonates born to women treated during pregnancy, no similar studies evaluating complications of oral nystatin have been conducted.

Nursing Mothers It is not known whether nystatin is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when nystatin is administered to a nursing woman. Pediatric Use See DOSAGE AND ADMINISTRATION section for pediatric dosing recommendations.

Adverse reactions

Adverse reactions (US label) US FDA label

ADVERSE REACTIONS Gastrointestinal symptoms including diarrhea, gastrointestinal distress, nausea, vomiting and burning of the mouth have been reported. Hypersensitivity reactions including rash, pruritus, and anaphylactoid reaction have also been reported.

Pharmacokinetics

Pharmacokinetics (US label) US FDA label

CLINICAL PHARMACOLOGY Nystatin acts by binding to sterols in the cell membrane of the fungus with a resultant change in membrane permeability allowing leakage of intracellular components. Nystatin is absorbed very sparingly following oral administration, with no detectable blood levels when given in the recommended doses.

Formulary and pricing (Philippines)

Government price references

PreparationPrice (PHP)UnitType
Nystatin 100,000 units/mL, 30 mL Suspension₱50.00–₱268.00Reference ₱155.00per unitDPRI procurement range

Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)

These are government procurement and reimbursement references, not retail prices. Sources:

Formulary and coverage

Philippine National FormularyListed as Nystatin
PNF listingOral: 100,000 units/mL suspension, 30 mL
PNF listingVaginal: 100,000 units per tablet
PhilHealth GAMOTNo

Sources:

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. Nystatin · Chartwell Governmental & Specialty RX, LLC [US FDA-approved label, version 1, November 12, 2025]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=88a0a22e-8d6b-42aa-b225-2d57fb5b3a97
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  3. PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
  4. DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .